Skip to main content
Clinical Trials/CTRI/2024/07/071640
CTRI/2024/07/071640
Not yet recruiting
未知

An Observational Study on the Effectiveness of Inji Chooranam II in Managing Annathuvedam (Anorexia) in the Paediatric Age Group: A Case Series - NI

Dr Somesh Balaji S0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K319- Disease of stomach and duodenum, unspecified
Sponsor
Dr Somesh Balaji S
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Somesh Balaji S

Eligibility Criteria

Inclusion Criteria

  • Children who are experiencing loss of appetite followed by flu or Upper Respiratory Tract infections
  • Children who have received any antibiotic treatment for flu or Upper Respiratory Tract infections
  • Children who are medically stable at the time of Study
  • Children and their guardians who are available for the duration of the Study period and able to follow up scheduled visits

Exclusion Criteria

  • Children with Chronic systemic diseases or any conditions known to affect appetite
  • Children receiving other AYUSH drug that might increase appetite
  • Children currently receiving other medication (except antibiotics) for other conditions that might affect appetite
  • Children with Neurological Conditions like CP, Autism that might affect feeding behavior or appetite independently

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A study to evaluate the usefulness and side effects of injection Remdesivir in moderate to severe covid 19 lung affected patients in a multispeciality hospital in Kolkata.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 3: B338- Other specified viral diseasesHealth Condition 4: J168- Pneumonia due to other specified infectious organisms
CTRI/2021/02/031541nil63
Completed
Phase 3
Investigating the effect of injectable Acetaminophen in the treatment of Patent Ductus Arteriosus (PDA).
IRCT20230219057459N1Kerman University of Medical Sciences80
Not yet recruiting
Phase 3
Comparison of the effect of platelet-rich plasma injection activated by light radiation with platelet-rich plasma injection in the treatment of arthritis
IRCT20140907019073N7Iran University of Medical Sciences40
Recruiting
Phase 3
Comparison of the efficacy of platelet-enriched plasma injection and laser on knee arthrosis
IRCT20140907019073N6Iran University of Medical Sciences60
Not yet recruiting
Not Applicable
To evaluate and compare the effects of injectable platelet-rich fibrin (i-PRF) which is a third generation platelet concentrate and micro-osteoperforation (MOP) also known as flapless bone puncturing on the rate of canine movement during retraction in patients requiring premolar extractions.Health Condition 1: K039- Disease of hard tissues of teeth,unspecified
CTRI/2022/12/048404KUSHAL TAORI